News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
97P Neoadjuvant D+GemCis vs gemcis alone for localized biliary tract cancer
Dec 10, 2024, 13:53

97P Neoadjuvant D+GemCis vs gemcis alone for localized biliary tract cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute and Post DM senior resident at AIIMS, New Delhi, shared on X:

”97P Neoadjuvant durvalumab plus gemcitabine and cisplatin (D+GemCis) versus gemcis alone for localized biliary tract cancer (BTC): Results of a randomized, multicenter, open-label, phase II trial (DEBATE) – Annals of Oncology”

Authors: C. Yoo, J.O. Park, K-P. Kim, J. Hyung, B-Y. Ryoo, J.Y. Hong, S.H. Shin, T.J. Song,  D. Oh, W. lee, B.J. Kwak, J.H. Lee, D.W. Hwang

97P Neoadjuvant D+GemCis vs gemcis alone for localized biliary tract cancer

Akhil Santhosh Annals of Oncology B-Y. Ryoo B.J. Kwak C. Yoo cancer D. Oh D.W. Hwang J. Hyung J.H. Lee J.O. Park J.Y. Hong K-P. Kim OncoDaily Oncology S.H. Shin T.J. Song W. lee
Special Coverage
Insight
Apr 1, 2025, 07:47
AACR GENIE 17.0 release provides insights into its genomic landscape
Blog
Apr 1, 2025, 07:32
Shravan Nadkarni: Registration is open for the Laparoscopic Colorectal Surgery Live Workshop
Science
Apr 1, 2025, 07:29
Talha Badar: Predictors of CNS relapse in APL
Blog
Apr 1, 2025, 07:24
Jenny Seligmann: World-class discovery science and clinicians collaborating on colorectal trial cohorts
Opinion
Apr 1, 2025, 07:19
Yüksel Ürün: Low-dose CT for lung cancer screening in a high-risk population
Blog
Apr 1, 2025, 07:09
Virginia Galvín: Should critical medications be integrated into defense budgets?
Blog
Apr 1, 2025, 06:51
Kendra Paabo: The 3 worst words you can say to someone with cancer
Blog
Apr 1, 2025, 06:49
Ali Atoui: Honored to Receive the 2025 CHAMP Award from the American Society of Hematology
Drugs
Apr 1, 2025, 06:49
Tislelizumab (Tevimbra): What Patients need to know?
Blog
Apr 1, 2025, 06:34
Trainee Day provided a space for trainees to connect and grow within the EBMT community
Blog
Apr 1, 2025, 06:20
Abhishek Chatterjee: The inaugural Stryker Breast Care Oncoplastic Surgery course has finished
Insight
Apr 1, 2025, 04:51
MD Anderson Cancer Center broke ground on a new 470,000-square-foot facility in Sugar Land